Marta Maddalo1,2, Michela Buglione3, Nadia Pasinetti4, Luca Triggiani3, Ludovica Pegurri3, Alessandro Magli5, Stefano M Magrini3, Barbara A Murphy6. 1. Department of Radiation Oncology, ASST Spedali Civili di Brescia - Brescia University, Brescia, Italy. marta.maddalo@gmail.com. 2. Department of Radiation Oncology, Brescia University - Istituto del Radio "O. Alberti", Spedali Civili Hospital, Piazzale Spedali Civili 1, 25123, Brescia, Italy. marta.maddalo@gmail.com. 3. Department of Radiation Oncology, ASST Spedali Civili di Brescia - Brescia University, Brescia, Italy. 4. Department of Radiation Oncology, Ospedale di Esine - ASL Vallecamonica-Sebino, Esine, Italy. 5. Department of Radiation Oncology, University Hospital of Udine, ASUIUD, Udine, Italy. 6. Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Abstract
PURPOSE: Patient-reported outcome measures can be useful to assess symptoms in head and neck cancer (HNC) patients treated with radio-chemotherapy. This is a pilot study on the VHNSS-IT (the Italian version of the Vanderbilt head and neck symptom survey) performed to assess both the feasibility and utility of its administration in clinical practice. METHODS: The outcomes analyzed were feasibility to recruit patients, feasibility to complete the questionnaire, feasibility to review the questionnaire, utility perceived by clinicians, distribution of patient's answers reflecting symptom's intensity. RESULTS: Among the 38 patients enrolled, 37 completed the VHNSS-IT (refusal rate 2.6%). Median time of completion was 6'57″. Time of completion was influenced by age (p = 0.002), grade of education (p = 0.023) and employment status (p = 0.004). Time after the start of the radiotherapy course (< 6 months vs. > 6 months) and surgery (yes vs. no) influenced symptoms' intensity. Median time for review was 2'15″. Time burden was perceived to be acceptable for all clinicians; they all also found the questionnaire easy to use. Rates of global perceived utility and future intention to use the questionnaire were 100%. CONCLUSIONS: The VHNSS-IT has demonstrated to be a useful measurement of symptoms' burden for patients with HNC. The survey can be easily completed during the clinic routine without interfering with doctors' visits schedule, and it can help healthcare providers to identify symptoms that require referral, education or intervention.
PURPOSE:Patient-reported outcome measures can be useful to assess symptoms in head and neck cancer (HNC) patients treated with radio-chemotherapy. This is a pilot study on the VHNSS-IT (the Italian version of the Vanderbilt head and neck symptom survey) performed to assess both the feasibility and utility of its administration in clinical practice. METHODS: The outcomes analyzed were feasibility to recruit patients, feasibility to complete the questionnaire, feasibility to review the questionnaire, utility perceived by clinicians, distribution of patient's answers reflecting symptom's intensity. RESULTS: Among the 38 patients enrolled, 37 completed the VHNSS-IT (refusal rate 2.6%). Median time of completion was 6'57″. Time of completion was influenced by age (p = 0.002), grade of education (p = 0.023) and employment status (p = 0.004). Time after the start of the radiotherapy course (< 6 months vs. > 6 months) and surgery (yes vs. no) influenced symptoms' intensity. Median time for review was 2'15″. Time burden was perceived to be acceptable for all clinicians; they all also found the questionnaire easy to use. Rates of global perceived utility and future intention to use the questionnaire were 100%. CONCLUSIONS: The VHNSS-IT has demonstrated to be a useful measurement of symptoms' burden for patients with HNC. The survey can be easily completed during the clinic routine without interfering with doctors' visits schedule, and it can help healthcare providers to identify symptoms that require referral, education or intervention.
Entities:
Keywords:
Head and neck cancer; Patient-reported outcome measure; Symptoms screening
Authors: Emily Cooperstein; Jill Gilbert; Joel B Epstein; Mary S Dietrich; Stewart M Bond; Sheila H Ridner; Nancy Wells; Anthony Cmelak; Barbara A Murphy Journal: Head Neck Date: 2011-08-24 Impact factor: 3.147
Authors: F Steiner; J Evans; R Marsh; P Rigby; S James; K Sutherland; R Wickens; N Nedev; B Kelly; S T Tan Journal: Int J Oral Maxillofac Surg Date: 2015-01-07 Impact factor: 2.789
Authors: Junya Zhu; Roger B Davis; Sherri O Stuver; Donna L Berry; Susan Block; Jane C Weeks; Saul N Weingart Journal: Cancer Date: 2012-06-06 Impact factor: 6.860
Authors: Jan-Willem G H Wetzels; Matthias A W Merkx; Anton F J de Haan; Ron Koole; Caroline M Speksnijder Journal: Head Neck Date: 2014-01-30 Impact factor: 3.147
Authors: Min Jin; Li Sun; Rui Meng; Wenjing Wang; Rui Sun; Jing Huang; You Qin; Bian Wu; Qian Ding; Gang Peng; Tao Zhang; Kunyu Yang Journal: Health Qual Life Outcomes Date: 2021-01-21 Impact factor: 3.186